|
|
Line 38: |
Line 38: |
| * (a) Each licensee shall submit a written report within 30 days after learning of any of the following occurrences: | | * (a) Each licensee shall submit a written report within 30 days after learning of any of the following occurrences: |
| * (2) Doses in excess of any of the following: | | * (2) Doses in excess of any of the following: |
| * ..
| |
| * (iv) The limits for an individual member of the public in 10 CFR 20.1301; 6 | | * (iv) The limits for an individual member of the public in 10 CFR 20.1301; 6 |
| 3 | | 3 |
Latest revision as of 12:51, 1 February 2020
|
---|
Category:Meeting Briefing Package/Handouts
MONTHYEARML24226A4582024-08-29029 August 2024 Financial Assurance Requirements for Disposition of Category 1-3 Byproduct Material Radioactive Sealed Sources Handout August 29 2024 Meeting ML24229A0942024-08-19019 August 2024 8-19-24 Meeting with NEI on Pirts - NRC Slides Final ML24207A0262024-08-13013 August 2024 Publicmeeting_Presentation for August_14_2024--FusionMachines_ProposedRule ML24192A1272024-07-10010 July 2024 Scale and Melcor non-LWR Fuel Cycle Demonstration Project - MSR ML24164A2372024-06-17017 June 2024 ACMUI Extravasations Handout June 17 2024 Meeting ML24149A1882024-06-0505 June 2024 ACMUI June 5 2024 Meeting Handout ML24075A1722024-02-22022 February 2024 Attachment 1 - NMMSS Trtr Presentation ML24029A2362024-01-30030 January 2024 Preliminary Results of the Environmental Review, Subsequent License Renewal ML23355A1432024-01-17017 January 2024 January 17, 2024 Public Meeting Handout - Fusion Systems Rulemaking ML23258A1802023-11-0909 November 2023 November 9, 2023 Public Meeting Presentation--Fusion Systems Proposed Rule ML23296A1992023-11-0808 November 2023 Cumulative Effects of Regulation Public Meeting (11/08/2023): Renewing Nuclear Power Plant Operating Licenses Environmental Review (Rin 3150-AK32; NRC-2018-0296) ML23258A1712023-11-0101 November 2023 November 1, 2023 Public Meeting Presentation--Fusion Systems Proposed Rule ML23240A7182023-08-29029 August 2023 Slides - Public Meeting on Regulatory Basis for Rb-82 Generators, Emerging Medical Technologies, and Other Medical Use of Byproduct Material ML23191A1532023-07-12012 July 2023 Public Meeting Presentation -- Proposed Rule: Regulatory Framework for Fusion Energy Systems ML23123A3292023-06-0606 June 2023 SGI Training ML13108A326 ML23123A3322023-06-0606 June 2023 SGI Pamphlet ML23062A7352023-04-14014 April 2023 Tanana Chiefs Conference 2023 Annual Convention NRC Presentation ML23137A0442023-04-11011 April 2023 April 11, 2023, Presentation to NOAA Narw Northeast U.S. Implementation Team - North Atlantic Right Whale and NRC Endangered Species Act Consultations ML23086C0722023-03-27027 March 2023 Presentation Slide for Monticello Scoping Webinar, March 29, 2023 ML23081A0392023-03-22022 March 2023 Presentation Slide for Monticello Public Scoping Meeting, March 22, 2023 ML23019A0122023-01-19019 January 2023 Inspection Manual Chapter 2602 and Associated Inspection Procedures Awareness Training for NRC & Agreement State Inspectors ML23012A2302023-01-12012 January 2023 Inspection Manual Chapter 2602 and Associated Inspection Procedures Public Presentation - Decommissioning Fuel Cycle, Uranium Recovery & Materials Inspection Program ML23006A0232022-12-15015 December 2022 NEIs Presentation for the December 15, 2022 Spent Fuel Priorities Meeting with NEI ML22334A1022022-12-0505 December 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Fall 2022 Meeting Handout ML22334A2692022-11-30030 November 2022 Advisory Committee on the Medical Uses of Isotope (ACMUI) Fall 2022 Meeting Handout (Revised) ML22326A2222022-11-23023 November 2022 Future of the National Materials Program Working Group Public Meeting: Presentation ML22311A5532022-11-16016 November 2022 Kairos Hermes NRC Staff Presentation at Nov 16 Public Meeting on the Draft Environmental Impact Statement for the Construction Permit for the Kairos Hermes Test Reactor ML22308A0502022-11-0303 November 2022 Presentation 2 Chapman NRC Background Slides Nov 3 2022 Discrete Radioactive Particle (DRP) Workshop ML22308A0512022-11-0303 November 2022 Presentation 3b Parks DRP Exposure Scenarios November 3, 2022 DRP Workshop Presentation ML22301A1612022-10-28028 October 2022 Discussion Questions for DRP Workshop ML22286A0712022-10-25025 October 2022 Harmonization of Transportation Safety Requirements with International Atomic Energy Agency Standards (Rin 3150-AJ85; NRC-2016-0179); Public Meeting Presentation ML22272A0392022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53 - SECY-23-XXXX Enclosure 1C Part 2 Through Part 53 Framework a Rule Language ML22272A0362022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53 - SECY-23-XXXX Enclosure 1A Preamble (E.G. Statements of Consideration) ML22272A0382022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53 - SECY-23-XXXX Enclosure 1B Section-by-Section, Backfit and Issue Finality, and Availability of Guidance Documents ML22272A0402022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53 - SECY-23-XXXX Enclosure 1D Part 53 Framework B Through Part 171 Rule Language ML22272A0422022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53 - DG-1413 Technology-Inclusive Identification of Licensing Events for Commercial Nuclear Plants ML22272A0472022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53 - DRO-ISG-2023-01 Operator Licensing Programs ML22272A0452022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53 - DG-1414 Alternative Evaluation for Risk Insights (Aeri) Methodology ML22272A0512022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53- DRO-ISG-2023-03 Development of Scalable Human Factors Engineering Review Plans ML22272A0492022-09-29029 September 2022 10/18-19/2022 ACRS Public Meeting - Predecisional - Documents to Support Part 53 - DRO-ISG-2023-02 Guidance for Assessing Exemption Requests from the Nuclear Power Plant Licensed Operator Staffing Requirements Specified in 10 CFR Part 50.54 ML22238A2542022-08-31031 August 2022 Slides - Reporting Events and Event Trending, 2022 Annual OAS Meeting ML22124A3012022-04-25025 April 2022 Dialog Presentation for Mashpee Wampanoag Tribe Regarding Pilgrim Liquid Effluent Discharges, April 25, 2022 ML22137A3232022-04-0505 April 2022 NRC 2022 and ACMUI 2021 Medical Event Summary Presentations ML22112A1042022-04-0505 April 2022 NRC Staff Medical Event Slide, April 5, 2022, FY21 ML22089A1892022-04-0505 April 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Handout ML22094A1022022-04-0505 April 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Revised Handout ML22097A1412022-03-24024 March 2022 Part 53 Rulemaking - Advanced Reactor Applications Presentation on March 24, 2022 ML22097A1312022-03-23023 March 2022 Decommissioning Rulemaking Presentation on March 23, 2022 ML22041A3752022-02-0909 February 2022 Document to Support ACRS Subcommitee Meeting - Redline Standard Review Plan 1.0 Introduction and Interfaces ML22041A4442022-02-0909 February 2022 Document to Support ACRS Subcommittee Meeting - Redline Standard Review Plan 13.3 Emergency Planning 2024-08-29
[Table view]Some use of "" in your query was not closed by a matching "". Category:Slides and Viewgraphs
MONTHYEARML24226A4582024-08-29029 August 2024 Financial Assurance Requirements for Disposition of Category 1-3 Byproduct Material Radioactive Sealed Sources Handout August 29 2024 Meeting ML24229A0942024-08-19019 August 2024 8-19-24 Meeting with NEI on Pirts - NRC Slides Final ML24207A0262024-08-13013 August 2024 Publicmeeting_Presentation for August_14_2024--FusionMachines_ProposedRule ML24192A1272024-07-10010 July 2024 Scale and Melcor non-LWR Fuel Cycle Demonstration Project - MSR ML24149A1882024-06-0505 June 2024 ACMUI June 5 2024 Meeting Handout ML24086A5442024-03-14014 March 2024 RIC 2024 TH24 Intro/Closing Slides on Navigating the Future of Fusion ML24040A1722024-03-12012 March 2024 RIC 2024 T4 Slides - Jlubinski Chair Intro Remarks ML24075A1722024-02-22022 February 2024 Attachment 1 - NMMSS Trtr Presentation ML24029A2362024-01-30030 January 2024 Preliminary Results of the Environmental Review, Subsequent License Renewal ML23355A1442024-01-17017 January 2024 January 17, 2024 Public Meeting Presentations - Fusion Systems Rulemaking ML23258A1802023-11-0909 November 2023 November 9, 2023 Public Meeting Presentation--Fusion Systems Proposed Rule ML23296A1992023-11-0808 November 2023 Cumulative Effects of Regulation Public Meeting (11/08/2023): Renewing Nuclear Power Plant Operating Licenses Environmental Review (Rin 3150-AK32; NRC-2018-0296) SECY-21-0109, 11/2/2023 ACRS Full Committee Meeting: Increased Enrichment of Conventional and Accident Tolerant Fuel Designs for Light-Water Reactors2023-11-0202 November 2023 11/2/2023 ACRS Full Committee Meeting: Increased Enrichment of Conventional and Accident Tolerant Fuel Designs for Light-Water Reactors ML23258A1712023-11-0101 November 2023 November 1, 2023 Public Meeting Presentation--Fusion Systems Proposed Rule ML23258A1472023-10-11011 October 2023 October 11, 2023 Public Meeting Presentation--Fusion Systems Proposed Rule ML23241A9492023-09-0606 September 2023 09-06-2023 Rulemaking: Proposed Rule: Public Meeting Slides - ASME 2021-2022 Code Editions Proposed Rule ML23240A7182023-08-29029 August 2023 Slides - Public Meeting on Regulatory Basis for Rb-82 Generators, Emerging Medical Technologies, and Other Medical Use of Byproduct Material ML23191A1532023-07-12012 July 2023 Public Meeting Presentation -- Proposed Rule: Regulatory Framework for Fusion Energy Systems ML23200A3452023-06-20020 June 2023 National Organization of Test, Research, and Training Reactors 2023 Annual Conference Presentation by Jack Parrott on Decommissioning ML23186A0212023-06-0808 June 2023 Spent Nuclear Fuel Shipments in the Us: Addressing the Myths ML23123A3292023-06-0606 June 2023 SGI Training ML13108A326 ML23123A3322023-06-0606 June 2023 SGI Pamphlet ML23130A0332023-05-11011 May 2023 NRC Presentation Browns Ferry Subsequent License Renewal Pre-application Meeting, Environmental Overview ML23062A7352023-04-14014 April 2023 Tanana Chiefs Conference 2023 Annual Convention NRC Presentation ML23102A0522023-04-12012 April 2023 Meeting Slide: Information Meeting with Federally-Recognize Tribes Regarding the Proposed Rule Renewing Nuclear Power Plant Operating Licenses Environmental Review ML23137A0442023-04-11011 April 2023 April 11, 2023, Presentation to NOAA Narw Northeast U.S. Implementation Team - North Atlantic Right Whale and NRC Endangered Species Act Consultations ML23086C0722023-03-27027 March 2023 Presentation Slide for Monticello Scoping Webinar, March 29, 2023 ML23081A0392023-03-22022 March 2023 Presentation Slide for Monticello Public Scoping Meeting, March 22, 2023 ML23069A0132023-03-10010 March 2023 Pubic Meeting Slides - Proposed Rule: Renewing Nuclear Power Plant Operating Licenses - Environmental Review (Rin 3150-AK32; NRC-2018-0296) ML23019A0122023-01-19019 January 2023 Inspection Manual Chapter 2602 and Associated Inspection Procedures Awareness Training for NRC & Agreement State Inspectors ML23012A2302023-01-12012 January 2023 Inspection Manual Chapter 2602 and Associated Inspection Procedures Public Presentation - Decommissioning Fuel Cycle, Uranium Recovery & Materials Inspection Program ML23006A0232022-12-15015 December 2022 NEIs Presentation for the December 15, 2022 Spent Fuel Priorities Meeting with NEI ML22326A2222022-11-23023 November 2022 Future of the National Materials Program Working Group Public Meeting: Presentation ML22311A5532022-11-16016 November 2022 Kairos Hermes NRC Staff Presentation at Nov 16 Public Meeting on the Draft Environmental Impact Statement for the Construction Permit for the Kairos Hermes Test Reactor ML22308A0512022-11-0303 November 2022 Presentation 3b Parks DRP Exposure Scenarios November 3, 2022 DRP Workshop Presentation ML22308A0502022-11-0303 November 2022 Presentation 2 Chapman NRC Background Slides Nov 3 2022 Discrete Radioactive Particle (DRP) Workshop ML22301A1612022-10-28028 October 2022 Discussion Questions for DRP Workshop ML22286A0712022-10-25025 October 2022 Harmonization of Transportation Safety Requirements with International Atomic Energy Agency Standards (Rin 3150-AJ85; NRC-2016-0179); Public Meeting Presentation ML22238A2542022-08-31031 August 2022 Slides - Reporting Events and Event Trending, 2022 Annual OAS Meeting ML22203A0192022-08-30030 August 2022 Patient Release Brochure Medical-Chinese Language ML22203A0202022-08-30030 August 2022 Patient Release Brochure Medical-French Language ML22203A0212022-08-30030 August 2022 Patient Release Brochure Medical-Spanish Language ML22221A1402022-08-10010 August 2022 Enclosure 2 - SGI Awareness Training ML22221A1412022-08-10010 August 2022 Enclosure 3 - Protection of SGI Pamphlet ML22124A3012022-04-25025 April 2022 Dialog Presentation for Mashpee Wampanoag Tribe Regarding Pilgrim Liquid Effluent Discharges, April 25, 2022 ML22137A3232022-04-0505 April 2022 NRC 2022 and ACMUI 2021 Medical Event Summary Presentations ML22112A1042022-04-0505 April 2022 NRC Staff Medical Event Slide, April 5, 2022, FY21 ML22088A2252022-03-30030 March 2022 Kairos Environmental Audit Closeout Meeting Presentation ML22097A1412022-03-24024 March 2022 Part 53 Rulemaking - Advanced Reactor Applications Presentation on March 24, 2022 ML22097A1312022-03-23023 March 2022 Decommissioning Rulemaking Presentation on March 23, 2022 2024-08-29
[Table view]Some use of "" in your query was not closed by a matching "". |
Text
PreSubmittal Meeting with Exubrion Therapeutics November 6, 2019 Medical Radiation Safety Team Medical Safety and Events Assessment Branch Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards Agenda
- Introductions and opening remarks
- Necessary content for application
- NRC and Exubrion discussion
Notice of Review Presubmittal Application Intent (NOI) and meeting submitted submitted resubmit No Acceptance Public meeting letter issued Accepted summary for issued review? Acceptance Yes Review Requests for RAI Review Additional responses and Information (RAIs) submitted resubmit Issued No RAI Draft Technical Final TE responses Evaluation (TE)
Yes issued acceptable? issued 3
Tentative Schedule Milestone Tentative Date for Completion Presubmittal meeting held November 6, 2019 Application received Late November 2019 Acceptance review completed MidDecember 2019 RAIs issued MidJanuary 2020 RAI responses received MidFebruary 2020 Draft TE issued MidApril 2020 Comments on Draft TE received Late April 2020 Final TE issued Summer 2020 4
2
Public Dose Requirements
- 20.1301 Dose limits for individual members of the public (paraphrased)
- (a) Each licensee shall conduct operations so that
- (1) The total effective dose equivalent to individual members of the public from the licensed operation does not exceed 0.1 rem (1 mSv) in a year, and
- (2) The dose in any unrestricted area from external sources does not exceed 0.002 rem (0.02 millisievert) in any one hour 5
Reporting Criteria
- 10 CFR 20.2203 Reports of exposures, radiation levels, and concentrations of radioactive material exceeding the constraints or limits.
- (a) Each licensee shall submit a written report within 30 days after learning of any of the following occurrences:
- (2) Doses in excess of any of the following:
- (iv) The limits for an individual member of the public in 10 CFR 20.1301; 6
3
Public Dose Considerations
- These public dose limits apply to every dog, not to the average
- Licensees are responsible to ensure these dose limits are met
- Strong screening criteria are necessary to ensure public dose limits are met for proposed dose rate at time of release
- Instructions should not be relied upon as the primary way to ensuring dose limits are met 7
Public Dose Considerations (cont.)
- This dose limit is not an average but for any one hour
- Distances under a foot need to be considered.
- Screening criteria maybe necessary. Instructions can support screening criteria, but cannot be the primary method which the regulation is met.
8 4
Radiation Area
- 10 CFR 20.1003 Radiation area means an area, accessible to individuals, in which radiation levels could result in an individual receiving a dose equivalent in excess of 0.005 rem (0.05 mSv) in 1 hour1.157407e-5 days <br />2.777778e-4 hours <br />1.653439e-6 weeks <br />3.805e-7 months <br /> at 30 centimeters from the radiation source or from any surface that the radiation penetrates.
9 Current Issues
- Justification seems to focus on averages instead of individual dogs. Public dose limit is per dog.
- Current dose release proposal of 0.5 mR/hr at a 1 meter
- Significantly higher than recommended for Iodine131 in cats, which has a shorter half life
- Results in a radiation area. Proposed maximum dose rate at time of release cannot exceed this limit.
- Very unlikely 2 mrem in any one hour could be met following dog release
- Close contact would result in high doses very quickly, cannot be ignored 10 5
Current Issues (cont.)
- Measurement data needed. Attenuation for different size dogs needs to be demonstrated.
- Geometry, distances, and dose rate should be included
- Close contact (i.e. messages, dog with legs over person, lifting the dog, etc.)
- Assumptions need to be conservative or licensee will need strong assurance assumptions are met for each animal
- Figures to show distances would be helpful
- What about dose to a child?
- Licensees procedure if a dog cannot be released immediately 11 Current Issues (cont.)
12 6
Example Assumption Needing more Justification
- Additionally, in most postures of lapsitting, the dogs body will serve as a shield for most of the human torso for radiation coming from the dogs legs or the dog would be in such a position that the average distance would be a foot or more, i.e.
stretched out perpendicular to the humans legs or with the dogs legs pointed towards the humans knees. Therefore, dose rates and occupancy factors at a distance of 3 inches are not discussed further.
13 Information Needed*
- Proposed Generic Procedures for Release
- Proposed Screening Criteria
- Proposed Generic Instructions
- Technical Basis Supporting Proposal
- Review will only consider information submitted as part of proposal.
14 7
Introduction
- Identify information applicants will need to provide
- Administration Limitations, i.e.
- Maximum activity/isotope/form
- Minimum spacing between procedures
- Number of dogs treated per owner/home over what time period
- Training specific to Sn117m use 15 Proposed Generic Procedures for Release
- Assumptions and limitations
- Release dose rate or method to calculate dog specific release dose rates
- Boarding Information 16 8
Proposed Screening Criteria
- Define licensees responsibility to ensure 10 CFR Part 20 is met for each individual dog within their unique circumstances.
- Describe the screening criteria you propose the licensees submit with the applications.
- Provide procedural steps on how licensees are given highconfidence that screening is sufficient to ensure public dose limits are met.
- If screening initially shows dogs behavior could result in public dose limit being exceeded, describe if and how licensees will allow owners to demonstrate dogs can meet modified behavior to allow them to be re screened.
17 Proposed Generic Instructions
- What to do in the case of emergency or death
- Describe dose if instructions are not followed 18 9
Technical Basis Demonstrating Compliance
- Provide dose rate data for different size animals
- Figures demonstrating distances and geometry
- Justification for expected animal behavior
- Maximum doses with instructions and screening compliance
- Maximum dose with poor instruction compliance
- Maximum likely dose with no instructions and screening criteria 19 10